Lannett Company, Inc.  

(Public, NYSE:LCI)   Watch this stock  
Find more results for Cody Smith
49.51
Nov 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 26.66 - 59.44
Open     -
Vol / Avg. 0.00/957,083.00
Mkt cap 1.77B
P/E 18.30
Div/yield     -
EPS 2.70
Shares 35.76M
Beta 1.13
Inst. own 52%
Feb 4, 2015
Q2 2015 Lannett Company Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 11, 2014
Lannett Company Inc at Credit Suisse Healthcare Conference
Nov 3, 2014
Q1 2015 Lannett Company Inc Earnings Call
Nov 3, 2014
Q1 2015 Lannett Company Inc Earnings Release
Sep 8, 2014
Lannett Company Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 37.42% 20.88%
Operating margin 58.52% 32.18%
EBITD margin - 34.37%
Return on average assets 39.11% 22.39%
Return on average equity 44.71% 27.00%
Employees 399 -
CDP Score - -

Address

9000 State Rd
PHILADELPHIA, PA 19136-1615
United States - Map
+1-215-3339000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company�s products manufactured and/or sold are prescription products. The Company�s products containing Levo are produced and marketed with 12 varying potencies. In addition to generic Levo tablets, the Company also markets and distributes Unithroid tablets, a branded version of Levo, which is produced and marketed with 11 varying potencies. The Company�s Levo tablets are used to treat hypothyroidism and other thyroid disorders. The Company�s generic Levo tablets and Unithroid tablets are manufactured by Jerome Stevens Pharmaceuticals (JSP). As of June 30, 2012, the Company manufactured and/or distributed 30 products.

Officers and directors

Jeffrey Farber Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Arthur P. Bedrosian J.D. President, Chief Executive Officer, Director
Age: 68
Bio & Compensation  - Reuters
Martin P. Galvan CPA Chief Financial Officer, Vice President - Finance, Treasurer
Age: 61
Bio & Compensation  - Reuters
William F. Schreck Chief Operating Officer
Age: 65
Bio & Compensation  - Reuters
Robert Ehlinger Vice President - Logistics, Chief Information Officer
Age: 56
Bio & Compensation  - Reuters
Ernest J. Sabo Vice President - Regulatory Affairs, Chief Compliance Officer
Age: 65
Bio & Compensation  - Reuters
Kevin R. Smith Vice President - Sales and Marketing
Age: 53
Bio & Compensation  - Reuters
William R. Farber Ph.D. Chairman Emeritus
Age: 82
Bio & Compensation  - Reuters
David Drabik Independent Director
Age: 45
Bio & Compensation  - Reuters
James M. Maher Independent Director
Age: 61
Bio & Compensation  - Reuters